Medtronic PLC vs PPG Industries, Inc. — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while PPG Industries, Inc. trades at $103.96 (market cap $23.44B). The key difference: Medtronic PLC is far larger — about 4.8× PPG Industries, Inc.'s market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and PPG Industries, Inc. for 68 Days on average.
| MDT | PPG | |
|---|---|---|
Market Cap | $112.24B | $23.44B |
Volume | 105,663,236 | 2,064,777 |
Sector | Health | Basic Materials |
52-Week High | $105.35 | $131.56 |
52-Week Low | $73.75 | $94.34 |
Typical Hold Time | 63 Days | 68 Days |
Enterprise Value | $131.58B | $29.31B |
Dividend Yield | 3.28% | 2.81% |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
PPG trades at $105.45, up 0.35% today, with a bearish technical signal and mixed earnings history including a Q2 2026 miss. The company maintains solid profitability with a 9.57% net margin and 19.63% ROE, supported by $1.94B operating cash flow in 2025. Recent news highlights margin pressures in automotive refinish but also innovation initiatives and leadership appointments.
Outlook is cautiously optimistic given the 55% analyst buy rating and $130 consensus price target, implying 23% upside. Risks include segment-specific weakness and macroeconomic sensitivity, but strong cash generation and dividend payments provide stability. The stock offers value at a P/E of 15.13, though near-term performance hinges on Q3 2026 results due Oct 27.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →